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Abstract
TIMM50 is an essential component of the TIM23 complex, the
mitochondrial inner membrane machinery that imports cytosolic
proteins containing a mitochondrial targeting presequence into
the mitochondrial inner compartment. Whole exome sequencing
(WES) identified compound heterozygous pathogenic mutations in
TIMM50 in an infant patient with rapidly progressive, severe
encephalopathy. Patient fibroblasts presented low levels of
TIMM50 and other components of the TIM23 complex, lower mito-
chondrial membrane potential, and impaired TIM23-dependent
protein import. As a consequence, steady-state levels of several
components of mitochondrial respiratory chain were decreased,
resulting in decreased respiration and increased ROS production.
Growth of patient fibroblasts in galactose shifted energy produc-
tion metabolism toward oxidative phosphorylation (OxPhos),
producing an apparent improvement in most of the above features
but also increased apoptosis. Complementation of patient fibrob-
lasts with TIMM50 improved or restored these features to control
levels. Moreover, RNASEH1 and ISCU mutant fibroblasts only shared
a few of these features with TIMM50 mutant fibroblasts. Our
results indicate that mutations in TIMM50 cause multiple mito-
chondrial bioenergetic dysfunction and that functional TIMM50 is
essential for cell survival in OxPhos-dependent conditions.
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Introduction
The mammalian mitochondrial proteome is estimated to contain
about 1,500 proteins (Meisinger et al, 2008), but only 13 of them
are encoded by the mitochondrial DNA (mtDNA) and synthesized
in the mitochondrial matrix. The remaining proteins are encoded
by nuclear genes, synthesized on cytosolic ribosomes and then
imported into mitochondria by specific protein import machineries
located on both the outer and the inner mitochondrial membranes
(OMM and IMM, respectively; Sokol et al, 2014).
The translocase of the outer mitochondrial membrane (TOM)
complex is the common entry gate for all mitochondrial precursor
proteins and, in humans, it consists of eight subunits (Fig 1A).
TOMM20 and TOMM70 serve as receptors for mitochondrial precur-
sor proteins, being the latter responsible for engaging with the
multichaperone complex of Hsp70/Hsp90/TOMM34. The channel-
forming subunit is TOMM40 while TOMM22 both stabilizes the
complex and interacts with subunits of the translocase of the inner
mitochondrial membrane (TIM) complex. Additional small subunits,
TOMM5, TOMM6, and TOMM7, are involved in the assembly and
stability of the TOM complex (Kato & Mihara, 2008).
Over half of all mitochondrial proteins synthesized in the cytosol
as precursors contain a cleavable mitochondrial targeting sequence
(MTS) at their N-terminus. After crossing the OMM, these precur-
sors are directed to the TIM23 complex. The TIM23 complex is
mainly utilized by proteins targeted to the matrix but it is also partly
used for proteins directed to the IMM and the intermembrane space
(IMS; Dudek et al, 2013; Sokol et al, 2014; Straub et al, 2016). The
TIM23 core complex consists of TIMM23, TIMM17, and TIMM50.
TIMM17 occurs in two flavors, TIMM17A and TIMM17B, which are
ubiquitously expressed in human tissues. Along with TIMM23, they
form the channel in the IMM but they are never together in the same
TIM23 complex, playing TIMM17B a more active role in import than
TIMM17A (Sinha et al, 2014). TIMM50 serves as receptor that
brings the presequence proteins from the TOM complex to the chan-
nel-forming subunit TIMM23 (Sokol et al, 2014; Schulz et al, 2015).
In yeasts, Tim50 not only mediates the transfer of presequence
proteins from Tom40 to Tim23, but it is also responsible for main-
taining the Tim23-Tim17 channel closed at resting state, therefore
avoiding the dissipation of membrane potential (Meinecke et al,
2006). Two isoforms of TIMM50 have been described in humans: A
long TIMM50L (456 amino acids) isoform targeted to the nucleus
due to the presence of an internal nuclear localization signal (NLS;
Xu et al, 2005) and a short TIMM50S (353 amino acids) isoform
found in mitochondria as part of the TIM23 complex (Guo et al,
2004). Both isoforms have a helical transmembrane domain (TMD)
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and, unlike the yeast counterpart, a functional serine phosphatase
domain (FCP1-like domain), in addition to a predicted N-terminal
MTS with low similarity between the two isoforms (Fig 1B) (Guo
et al, 2004). Import of proteins targeted to the mitochondrial matrix
requires an electrochemical mitochondrial membrane potential
(DΨ) and ATP hydrolysis, in addition to the action of the prese-
quence translocase-associated motor (PAM) complex. This complex
dynamically associates with the TIM23 complex in the so-called
TIM23-PAM or TIM23MOTOR complex. Mortalin/HSP9 binds to the
precursor proteins and hydrolyzes ATP to pull them inside the orga-
nelle, and its attachment to the TIM23 complex is mediated by
TIMM44. PAM cochaperones MAGMAS, MCJ, DNAJC19, and GrpE
interact with the TIM complex and modulate the ATP-ase activity of
mortalin (Sokol et al, 2014; Schulz et al, 2015). Once in the
matrix, mitochondrial processing peptidases (MPP) remove the
presequences, generating the mature form of the imported proteins.
A functionally different TIM23 complex is involved in the insertion
of MTS-carrying proteins into the IMM, the TIM23SORT complex
(Sokol et al, 2014). In this case, the PAM complex is replaced by
TIMM21, and its interaction with the TIM23 complex is mediated by
ROMO1 (Sokol et al, 2014; Schulz et al, 2015).
Hydrophobic proteins with multiple segments spanning the
IMM and no cleavable MTS, such as metabolite carrier proteins, or
TIMM23, TIMM22, and TIMM17, require a different translocase,
the TIM22 complex (Dudek et al, 2013; Sokol et al, 2014; Straub
et al, 2016). A multimeric chaperone complex encompassing
TIMM9 and TIMM10, or less frequently TIMM8 and TIMM13,
shuttles these proteins from the TOM to the TIM22 complex.
Human TIM22 complex consists of the channel-forming subunit
TIMM22 and two mammalian specific constituents: the lipid kinase
A
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Figure 1. TIMM50 and the import machinery.
A Schematic structure of the human mitochondrial protein import machinery showing the components of the translocase of the outer (TOM) and inner membrane
(TIM23-PAM and TIM22).
B Human TIMM50 isoforms (top), TIMM50L and TIMM50S, consist of three domains: a mitochondrial targeting sequence (MTS) that directs the protein to mitochondria,
a transmembrane domain (TMD), and a presequence binding domain (PBD) that contains an active phosphatase FCP1-like domain. Isoform TIMM50L also contains a
nuclear localization signal (NLS). Phylogenetic alignment of the human protein region containing the substitutions found in the affected individual is shown below.
Altered residues in the affected subject are boxed in red and its position marked in relation to conserved domains. Abbreviations are as follows: Hs, H. sapiens; Pt,
P. troglodytes; Bt, B. taurus; Mm, M. musculus; Rn, R. norvegicus; Xt, X. tropicalis; Dr, D. rerio; Dm, D. melanogaster; Ce, C. elegans; Sc, S. cerevisiae.
C TIMM50S levels in primary and immortalized skin fibroblast from control (C1–4) and mutant TIMM50 (Pt). SDHA and ETHE1 are shown as loading controls.
D qPCR quantification of TIMM50 transcript levels in control and TIMM50 mutant fibroblasts. Data are shown as mean  SD, n = 4.
Source data are available online for this figure.
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AGK and TIMM29 (Callegari et al, 2016; Kang et al, 2016; Vukotic
et al, 2017).
In humans, only six diseases have been associated with muta-
tions in nuclear genes encoding components of the mitochondrial
protein import machinery: three in the TIM23 and two in the TIM22
pathways and one in the disulfide relay system. The deafness–dysto-
nia syndrome (or Mohr–Tranebjaerg syndrome) is an X-linked
neurodegenerative disorder caused by mutations of the DDP1
(TIMM8A) gene (Jin et al, 1996; Koehler et al, 1999). This protein is
a component of the TIM22 pathway and mediates the insertion of
metabolite carriers into the IMM. Mutations in DNAJC19, encoding
a mitochondrial PAM chaperone protein, are associated with an
autosomal recessive disorder characterized by dilated cardiomyopa-
thy with ataxia (DCMA) (Davey et al, 2006; Ojala et al, 2012).
Patients with mutations in GFER (ALR) encoding a mitochondrial
intermembrane space protein involved in the regeneration of redox-
active disulfide bonds in MIA40 presented autosomal recessive
progressive mitochondrial myopathy with congenital cataract, hear-
ing loss, and developmental delay (Di Fonzo et al, 2009). Mutations
in MAGMAS, encoding a mitochondrial PAM chaperone protein, are
associated with severe spondylodysplastic dysplasia and link mito-
chondria to the ossification process (Mehawej et al, 2014). Sengers
syndrome is an autosomal recessive disorder characterized by
congenital cataracts, hypertrophic cardiomyopathy, skeletal myopa-
thy, and exercise intolerance caused by mutations in AGK (Aldah-
mesh et al, 2012; Mayr et al, 2012; Haghighi et al, 2014), encoding
a protein only recently described as a component of the TIM22
complex (Vukotic et al, 2017). Finally, mutations in TIMM50,
coding for a core subunit of the TIM23 complex, have been reported
in siblings from two unrelated families with severe intellectual
disability and seizures, slightly elevated lactate levels, 3-methylglu-
taconic aciduria and, in one subject, deficiency of mitochondrial
complex V (Shahrour et al, 2017).
In this report, we present a thorough molecular dissection of
fibroblasts from a patient belonging to a third unrelated family,
affected by severe epilepsy and lactic acidosis, with impaired TIM23
complex due to compound heterozygous mutations in TIMM50.
Results
Whole exome sequencing
A detailed description of the case report of our patient and a clinical
discussion of all the reported cases of TIMM50 mutations are
presented in the supplemental material online, including brain
magnetic resonance imaging and spectroscopy (Appendix Fig S1).
The clinical course, neuroimaging, and biochemical results pointed
to an OxPhos-related mitochondrial disorder. Whole exome
sequencing and subsequent filtering steps, assuming a recessive trait
and focusing on genes encoding mitochondrial proteins, identified
two heterozygous variants in TIMM50 (NM_001001563,
NP_001001563): a c.335C>A substitution in exon 1, predicted to
cause a nonsense mutation p.S112*, and a c.569G>C in exon 3,
predicted to produce a missense change (p.G190A; Fig 1B). Sanger
sequencing confirmed the two variants in the proband and showed
that the two parents were each heterozygous for one of them
(Appendix Fig S2A). The nonsense change was not reported in the
ExAc database, while the c.569G>C (rs776019250) was present in
only 1 out of > 200,000 alleles. Moreover, the p.G190A aa change
occurs in a conserved residue of the protein at the C-terminus of the
transmembrane domain and is predicted as “damaging” by different
bioinformatics tools.
TIM-TOM complex protein levels and membrane potential
TIMM50 has been reported in two different isoforms, a nuclear
TIMM50L and a mitochondrial TIMM50S, translated from two dif-
ferent transcripts of the same gene. Bioinformatics analyses
predicted a mitochondrial targeting signal in both isoforms but also
a nuclear localization signal in TIMM50L (Fig 1B). Since only
TIMM50S is reported in mitochondria, we will only focus on this
isoform and refer to it as TIMM50. The levels of TIMM50 are higher
in the control than in patient fibroblasts, both primary and immor-
talized (Figs 1C and 2A, and Appendix Fig S2B). Indeed, qPCR anal-
ysis showed a reduction of about 40% of TIMM50 transcripts in
patient fibroblasts, suggesting nonsense-mediated decay of the c.569
G>C (p.S112*) mutant mRNAs (Fig 1D).
TIMM50 is a core component of the mitochondrial protein
import machinery, and therefore, we investigated how the muta-
tions present in the patient affected the protein levels of other
import components. When the cells were grown in glucose, we
detected significantly lower levels of TIMM50 (24–26% of controls)
associated with significantly lower levels of the other three compo-
nents of the TIM23 complex, TIMM17A, TIMM17B, and TIMM23
(3–12%, 14–18% and 15–18%, respectively) and small reduction
in DNAJC19 (43–50% of controls; Fig 2A and Appendix Fig S3A).
Other components of the PAM complex, channel-forming TIMM22
or subunits of the TOM complex, and its chaperones were not
affected, suggesting that the phenotype was exclusively dependent
on the TIM23 complex (Fig 2A and Appendix Fig S3A). When
fibroblasts were grown in galactose, we observed lower levels of
all four TIM23 components and DNAJC19 compared to controls,
albeit with higher values than in glucose (Fig 2A and
Appendix Fig S3A). This trend was also detected in the other
components of the import machinery, with the exception of
TOMM40 and TOMM22 that showed lower levels in galactose than
in glucose. However, we detected no significant differences
between control and patient cells in galactose, except for TOMM34
which was significantly decreased in the patient compared to
controls (Fig 2A and Appendix Fig S3A). Furthermore, in the
patient cells, the levels of the different proteins are more similar in
galactose, where most of them range 0.4–0.7 relative to GAPDH
taken as a standard, than in glucose, where TIM23 complex subu-
nits have a value of 0.3 or lower, while all the other proteins are
close to 1 (Appendix Fig S3A). By contrast, in control fibroblasts,
protein levels were very similar either in glucose or in galactose
(Appendix Fig S3A), suggesting that this may represent a charac-
teristic feature of a functionally proficient import machinery. When
patient fibroblasts were transduced with TIMM50, comparable
levels of TIMM50 to transduced control cells were observed
(Fig 2B and Appendix Fig S3B). Furthermore, the levels of
complex TIM23 proteins and DNAJC19 were also significantly
increased (Fig 2B and Appendix Fig S3B).
Mitochondrial membrane potential is frequently altered in cases
of mitochondrial dysfunction, including mutations in TIMM50 that
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make the system leaky, as reported in yeast (Meinecke et al, 2006),
or alterations in the electron transport chain, impairing proton
translocation across the IMM. TIMM50 mutant fibroblasts displayed
significantly lower mitochondrial potential in both glucose and
galactose. However, the membrane potential was not completely
collapsed since the addition of the uncoupler FCCP resulted in a
further decrease in membrane potential in all cases (Fig 2C).
Complementation of mutant fibroblasts with transduced TIMM50
increased the membrane potential almost to the level of control cells
(Fig 2C). Live staining of fibroblasts with the membrane potential-
dependent dye TMRM confirmed the lower membrane potential in
the patient fibroblasts grown in glucose, with mild improvement
when grown in galactose and a significant improvement when trans-
duced with TIMM50 (Fig 2D and Appendix Fig S4A and B).
Import through the TIM23 and the TIM22 complexes
In order to assess whether the TIMM50 mutations affect import
pathways, we synthesized TFAM and AAC1 polypeptides in a cell-
free system and performed protein import experiments into mito-
chondria isolated from control and patient fibroblasts (Fig 3).
TFAM import into mitochondria occurs in a membrane potential-
dependent way (Fig 3A, Reyes et al, 2011), and as a matrix protein
with a cleavable MTS, the import of TFAM is carried out by the
TIM23 pathway. Mitochondria from control fibroblasts were able
to import TFAM over time while its import in patient mitochondria
was severely impaired (Fig 3A and B). AAC1 import into mito-
chondria also occurs in a membrane potential-dependent way but
using the TIM22 pathway instead (Fig 3A, Vukotic et al, 2017).
A
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Figure 2. Decreased TIM23 complex and membrane potential in TIMM50 mutant fibroblasts.
A Western blot of whole cell extracts for different components of the protein import machinery in control and TIMM50 mutant fibroblasts grown in either glucose- or
galactose-containing medium.
B Western blot of whole cell extracts for different components of the protein import machinery in control and TIMM50 mutant fibroblasts, transduced with the empty
vector (EV) or with wild-type TIMM50 grown in either glucose- or galactose-containing medium.
C Mitochondrial membrane potential in fibroblasts grown in glucose or galactose using JC-1 staining in untreated or FCCP-treated conditions. Data are shown as
mean  SD, n = 4 biological replicates; *P < 0.05, **P < 0.01, ***P < 0.001, Student’s unpaired two-tailed t-test. Exact P-values are reported in Table EV1.
D TMRM live staining of control and TIMM50 mutant fibroblasts, transduced with the empty vector (EV) or with wild-type TIMM50 grown in either glucose- or
galactose-containing medium. Scale bar corresponds to 10 lm. A digitally enhanced TMRM image from TIMM50 mutant fibroblasts is shown in Appendix Fig S4B.
Source data are available online for this figure.
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Notably, the decrease in TIM23 complex proteins had only a minor
effect (10–12% decrease at 30 min) in the import of this protein in
patient mitochondria, which contain normal levels of TIMM22
(Fig 3A and B), providing evidence that the residual mitochondrial
membrane potential observed in patient fibroblasts is enough to
allow import of proteins through the IMM. In agreement with the
import results, we observed lower steady-state levels of TFAM in
patient fibroblasts and no significant difference for AAC1
(Appendix Fig S4C). Mitochondria from patient fibroblasts trans-
duced with TIMM50 were able to import TFAM in a similar fash-
ion to transduced control (Fig 3C and D), demonstrating not only
that TIMM50 levels were increased but also that the function of
the TIM23 complex was restored. No significant changes were
observed for AAC1 import.
Changes in OxPhos proteins and oxygen consumption
Next, we investigated how the import impairment detected in
patient mitochondria would affect structural components of the
electron transport chain. OxPhos constituents of all five complexes
were analyzed by SDS–PAGE and Western blot. Patient fibroblasts
grown in glucose presented significantly lower steady-state levels
of all surveyed subunits of complex II and complex IV and one
complex I subunit, while no difference was observed for either
A
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Figure 3. TIM23 but not TIM22-dependent import is impaired in TIMM50 mutant fibroblasts.
A In organello import of the precursors of TFAM and AAC1 into isolated mitochondria from control and TIMM50 mutant fibroblasts in the absence or presence of the
uncoupler FCCP. The radiolabeled precursors were incubated with isolated mitochondria for the indicated times followed by trypsin treatment only in the case of
AAC1. Coomassie Blue (CB) staining was used as loading control and the radiolabeled protein (TNT) as reference for quantification. The position of the precursor
(empty arrowheads) and the mature protein (filled arrowhead) are also shown. Western blot for TIMM50 is shown as cell line control.
B Quantification of TFAM and AAC1 import from control and TIMM50 mutant fibroblasts expressed as fraction of the input radiolabeled precursor converted into
mature protein and normalized to Coomassie Blue signal. Data are shown as mean  SD, n = 3 biological replicates; *P < 0.05, **P < 0.01, ***P < 0.001 grouping
both controls together, Student’s unpaired two-tailed t-test. Exact P-values are reported in Table EV1.
C In organello import of the precursors of TFAM and AAC1 into isolated mitochondria from control and TIMM50 mutant fibroblasts transduced with the empty vector
(EV) or with wild-type TIMM50 in the absence or presence of the uncoupler FCCP as described in (A). The position of the precursor (empty arrowheads) and the
mature protein (filled arrowhead) are also shown.
D Quantification of TFAM and AAC1 import from control and TIMM50 mutant fibroblasts transduced with the empty vector (EV) or with wild-type TIMM50 expressed as
fraction of the input radiolabeled precursor converted into mature protein and normalized to Coomassie Blue signal. Data are shown as mean  SD, n = 3 biological
replicates; *P < 0.05. Exact P-values are reported in Table EV1.
Source data are available online for this figure.
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complex III or complex V subunits (Fig 4A and Appendix Fig
S5A). However, the decrease in MT-CO1 and MT-CO2 must be
secondary to the decrease of nuclear-encoded complex IV subunits
and/or to a reduction in the mitochondrial transcription/transla-
tion machinery, since both proteins are encoded by the mitochon-
drial DNA and therefore, they do not require to be imported.
Growth in galactose showed an overall increase of OxPhos
proteins, in agreement with increased biogenesis. Furthermore, no
differences between patient and control fibroblasts were observed
in galactose for either complex II or complex IV. In addition, all
complex III and one complex I subunit showed even higher values
in patient than in control fibroblasts in galactose (Fig 4A and
Appendix Fig S5A). These results are concordant with an apparent
improvement of protein levels of the import machineries in patient
fibroblasts grown in galactose (Fig 2A and Appendix Fig S3B).
Complementation of patient fibroblasts by TIMM50 transduction
increased the steady-state levels of subunits of complexes I, II, and
IV in glucose and decreased the levels of complexes I and III in
galactose to comparable values to transduced controls (Fig 4B and
Appendix Fig S5B).
A
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Figure 4. Altered OxPhos protein level and respiration in TIMM50 mutant fibroblasts.
A Western blot for representatives of all five respiratory complexes in control and TIMM50 mutant fibroblasts grown in glucose or galactose. Two biological replicates
are shown for each cell line and condition. Significant changes in protein levels in TIMM50 mutant fibroblasts compared to controls have been boxed in red. The
quantification is shown in Appendix Fig S3A.
B Western blot for representatives of all five respiratory complexes in control and TIMM50 mutant fibroblasts, transduced with the empty vector (EV) or with wild-type
TIMM50 grown in glucose or galactose. Two biological replicates were obtained for each cell line and condition. Significant changes in protein levels in TIMM50
mutant fibroblasts complemented with TIMM50 compared to EV have been boxed in red. The quantification is shown in Appendix Fig S3B.
C Oxygen consumption measurements in control and TIMM50 mutant fibroblasts grown in glucose or galactose. Values of basal and maximal respiration along with
ATP production-dependent, proton leak respiration, and spare capacity are shown. Data are shown as mean  SD, n = 4 biological replicates; *P < 0.05, **P < 0.01,
***P < 0.001 grouping both controls together, Student’s unpaired two-tailed t-test. Exact P-values are reported in Table EV1.
D Oxygen consumption measurements in control and TIMM50 mutant fibroblasts, transduced with the empty vector (EV) or with wild-type TIMM50 grown in glucose
or galactose. Values of basal and maximal respiration along with ATP production-dependent, proton leak respiration, and spare capacity are shown. Data are shown
as mean  SD, n = 4 biological replicates; *P < 0.05, **P < 0.01, ***P < 0.001, Student’s unpaired two-tailed t-test. Exact P-values are reported in Table EV1.
Source data are available online for this figure.
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Since we observed significant changes in protein levels for some
complex subunits, we then investigated what effect this may have
on mitochondrial respiration, by measuring oxygen consumption,
IO2. When grown in glucose, patient fibroblasts showed significantly
lower values than control in every single category: basal IO2, ATP-
dependent, proton leak, maximal, and spare IO2 capacity (Fig 4C).
Notably, ATP-dependent respiration was actually extremely low in
the patient fibroblasts, despite the normal levels of all complex V
subunits we analyzed (Fig 4A and Appendix Fig S5A). Galactose-
grown fibroblasts displayed higher values in basal IO2, ATP-depen-
dent, and maximal respiration than those grown in glucose. This
effect is likely due to a metabolic shift from glycolysis to OxPhos,
and it is also in agreement with the observed increase in protein
levels of respiratory chain complex subunits (Fig 4A and
Appendix Fig S5A). As a consequence, spare capacity is reduced
compared to glucose in all cases. Nevertheless, respiration was still
lower in patient than in control fibroblasts. However, ATP produc-
tion in patient fibroblasts reached values similar to those found in
control cells grown in glucose, which again points to an apparent
bioenergetics improvement of patient cells grown in galactose.
Basal, maximal, and ATP-dependent oxygen consumption were
significantly increased in patient fibroblasts transduced with
TIMM50 compared to those transduced with empty vector when
cells were grown in both glucose and galactose. However, oxygen
consumption values were still lower compared to those of trans-
duced controls in glucose, whereas they were similar in galactose
(Fig 4D). These results are also in agreement with the changes
detected in protein levels of respiratory chain complex subunits in
transduced patient fibroblasts (Fig 4B and Appendix Fig S5B).
ROS production
A possible direct consequence of dysfunctional OxPhos is the
increase of reactive oxygen species (ROS). ROS production, as
measured by intracellular oxidation of DCFDA, was higher in cells
grown in glucose than galactose (Fig 5A). When cells were left
untreated, patient fibroblasts only showed a marginal increase of
ROS levels at later time points. However, the pre-incubation with
exogenous hydrogen peroxide clearly enhanced the differences and
revealed significantly higher levels of ROS in the patient fibroblasts
in both glucose and galactose. To further verify these results, we
investigated the steady-state levels of two proteins related to oxida-
tive stress response and in particular to superoxide anion O2 detoxi-
fication, SOD2 and ACO2. While both proteins were significantly
upregulated in the patient fibroblasts and the effect was more
pronounced in galactose, SOD2 presented the highest increase
compared to control cells (Fig 5B and C). This increase was
reversed when patient fibroblasts were transduced with TIMM50
(Appendix Fig S6A–C).
Decreased mitochondrial potential and increased ROS production
have been associated with increased selective mitochondrial degra-
dation or mitophagy. Thus, we analyzed the levels of VDAC1, a
protein whose ubiquitination by Parkin can trigger ROS-mediated
mitophagy, as well as the ubiquitin-binding adaptor protein p62 and
the phagophore protein LC3. Patient fibroblasts grown in glucose
showed a significantly higher level of VDAC1 and lipidated LC3-II in
concomitance with a significant decrease of p62, resulting in higher
LC3-II/p62 ratio (Fig 5D and E) and pointing toward increased
mitophagy. Such differences were not observed when fibroblasts
were grown in galactose, being the increase in LC3-II in all samples
the most prominent change compared to the results obtained in
glucose (Fig 5D and E). Transduction of patient fibroblasts with
TIMM50 restored levels of VDAC1 and p62 and to some extent lipi-
dated LC3-II, to comparable levels to transduced control, in agree-
ment with the observed decrease in levels of SOD2 and ACO2
(Appendix Fig S6A and D–E).
Cell viability
In order to assess what impact mutations in TIMM50 and the subse-
quent mitochondrial alterations may have in the cell as a whole, we
measured cell size and cell growth in glucose- and galactose-
containing media (Fig 6). Patient fibroblasts were significantly
smaller than control in both glucose and galactose but their size
was increased in both conditions when they were transduced with
TIMM50 (Fig 6A). In addition, their growth rate in glucose was 50%
slower than controls but still able to reach confluency albeit with a
decrease in viability (Fig 6B and Appendix Fig S7). Transduction
with TIMM50 significantly improved patient fibroblast growth and
viability in glucose (Fig 6B and Appendix Fig S7). However, when
the cells were grown in galactose, a very limited growth was
observed (Fig 6B) despite all the apparent biochemical improve-
ments shown in the previous experiments. This growth defect was
reversed by transduction with TIMM50. This result could be due to
either lower division rate or increased cell death in galactose. There-
fore, we measured apoptosis in glucose and galactose conditions.
We observed no significant increase in apoptosis in glucose;
however, there was a fivefold increase in apoptotic cells when
patient fibroblasts were grown in galactose medium while no such
change was detected in controls; importantly, this phenotype was
lost after transduction with TIMM50 (Fig 6C and D).
RNASEH1 and ISCU patient fibroblasts
Immortalized fibroblasts derived from patients with mutations in
RNASEH1, coding for a protein involved in mtDNA maintenance
(Reyes et al, 2015) or ISCU, encoding a scaffold protein for the
assembly of iron-sulfur (Fe-S) clusters (Legati et al, 2017) have been
studied as additional cell models of mitochondrial disease in order
to establish if the reported changes were unique to mutant TIMM50
fibroblasts or shared with other disease cell lines. Steady-state levels
of the components of the mitochondrial protein import machinery
in RNASEH1, and ISCU mutant fibroblasts were not very different
from controls (Fig 7A and Appendix Fig S8A and B) except for
TOMM34 when cells were grown in galactose, as also observed in
TIMM50 mutant fibroblasts (Appendix Fig S8A). However, TFAM
and AAC1 mitochondrial import was not significantly affected in
these two cell lines (Appendix Fig S8C) despite both of them
displayed significantly lower mitochondrial membrane potential
than control (Fig 7B).
Analysis of OxPhos constituents of all five complexes revealed
that significant changes compared to control were only detected for
SDHB and COX4I1 in ISCU mutant fibroblasts grown in glucose and
MT-CO1 in both RNASEH1 and ISCU mutant fibroblasts grown in
galactose (Fig 7C and Appendix Fig S9). The most dramatic changes
detected in TIMM50 mutant fibroblasts, e.g., lower levels of
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NDUFS3 in glucose or the increase of NDUFS3 and complex III
components in galactose, were not present in the other two cell lines
(Fig 7C and Appendix Fig S9). In agreement with these results,
oxygen consumption, IO2, in RNASEH1 mutant fibroblasts was simi-
lar to controls in most cases and only slightly lower in ISCU mutant
fibroblasts grown in glucose, but always higher than in TIMM50
mutant fibroblasts. However, both cell lines showed moderately
lower oxygen consumption than controls when grown in galactose,
albeit significantly higher than TIMM50 mutant fibroblasts (Fig 7D).
As a consequence, the significant increase in proteins related to
oxidative stress response, SOD2 and ACO2, that we observed in
TIMM50 mutant fibroblasts was not present in RNASEH1 and ISCU
mutant fibroblasts (Fig 7E and Appendix Fig S10), and indeed, the
levels of ACO2 in ISCU mutant fibroblasts were actually lower then
controls as ACO2 is an iron-sulfur protein dependent on the activity
of the ISCU protein. By contrast, the levels of a protein involved in
ROS-mediated mitophagy, VDAC1, were significantly higher in ISCU
mutant fibroblasts than in controls but not so high as in TIMM50
mutant fibroblasts (Fig 7E and Appendix Fig S10). The only
common feature in all three patient fibroblast cell lines was the
A
C
B
D E
Figure 5. Increased ROS production and mitophagy in TIMM50 mutant fibroblasts.
A ROS production as measured by intracellular oxidation of the cell-permeant probe DCFDA in control and TIMM50 mutant fibroblasts grown in glucose or galactose.
Measurements were made in untreated cells and after treatment with 250 lM hydrogen peroxide for 30 min. Data are shown as mean  SD, n = 3 biological
replicates; *P < 0.05, **P < 0.01, ***P < 0.001 grouping both controls together, Student’s unpaired two-tailed t-test. Exact P-values are reported in Table EV1.
B Steady-state levels of ROS-related proteins SOD2 and ACO2 in control and TIMM50 mutant fibroblasts growing in either glucose or galactose were assessed by
Western blot using GAPDH as internal control.
C Quantification of the steady-state levels of SOD2 and ACO2 in control and TIMM50 mutant fibroblasts growing in either glucose or galactose. Data are shown as
mean  SD, n = 4 biological replicates; *P < 0.05, **P < 0.01 grouping both controls together, Student’s unpaired two-tailed t-test. Exact P-values are reported in
Table EV1.
D Steady-state levels of mitophagy-related proteins VDAC1, p62, and LC3-II in control and TIMM50 mutant fibroblasts growing in either glucose or galactose were
assessed by Western blot using GAPDH as internal control. GAPDH is from the same blot as panel (B).
E Quantification of the steady-state levels of VDAC1, p62, and LC3-II in control and TIMM50 mutant fibroblasts growing in either glucose or galactose. Data are shown
as mean  SD, n = 4 biological replicates; **P < 0.01, ***P < 0.001 grouping both controls together, Student’s unpaired two-tailed t-test. Exact P-values are reported
in Table EV1.
Source data are available online for this figure.
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significant low levels of p62 in glucose growth, that is persistent in
galactose growth only in the case of TIMM50 mutant fibroblasts
(Fig 7E and Appendix Fig S10).
ISCU but not RNASEH1 mutant fibroblasts were smaller than
controls, similar to TIMM50 mutant fibroblasts both in glucose- and
galactose-containing media (Appendix Fig S11A). Likewise,
RNASEH1 mutant fibroblasts displayed a marginal growth defect
compared to controls, while a growth defect was observed for ISCU
and TIMM50 mutant fibroblasts, with a severe impairment in galac-
tose, albeit consistently less pronounced in ISCU vs. TIMM50 mutant
fibroblasts (Appendix Fig S11B). Cell viability was not affected in
RNASEH1 and ISCU mutant fibroblasts as observed in TIMM50
mutant fibroblasts (Appendix Fig S11C) nor was the number of
apoptotic cells when cultured in galactose media (Fig 7F), a feature
that remains specific of TIMM50 mutant fibroblasts (Fig 6D).
Discussion
Two isoforms of TIMM50 have been described: a 353 aa-long mito-
chondrial isoform TIMM50S and a 456 aa-long nuclear isoform
TIMM50L (Xu et al, 2005). The official nomenclature of mutations
refers to the longer species, which has an alternative translational
start sequence adding 103 aa to the N-terminus. The nonsense muta-
tion p.S112* introduces a stop codon after 112 or 9 aa from the
initial methionine of TIMM50L and TIMM50S, respectively, and
A
C
B
D
Figure 6. Cell size, cell growth, and apoptosis in TIMM50 mutant fibroblasts.
A Cell size in control and TIMM50 mutant fibroblasts, transduced with the empty vector (EV) or with wild-type TIMM50 grown in glucose or galactose. Data are shown
as mean  SD, n = 5 biological replicates; *P < 0.05, **P < 0.01, ***P < 0.001, Student’s unpaired two-tailed t-test. Exact P-values are reported in Table EV1.
B Growth curves of control and TIMM50 mutant fibroblasts, transduced with the empty vector (EV) or with wild-type TIMM50 grown in glucose or galactose. Cell
growth was monitored continuously by the Incucyte live cell imager (Essen Bioscience). One of the three independent experiments carried out is presented. Data are
shown as mean of three technical replicates  SD.
C Plot of Annexin V intensity against propidium iodide signal in control and TIMM50 mutant fibroblasts, transduced with the empty vector (EV) or with wild-type
TIMM50 grown in glucose or galactose. Cells in the late stage of apoptosis are boxed in the top right corner.
D Quantification of the number of late apoptotic cells in control and TIMM50 mutant fibroblasts, transduced with the empty vector (EV) or with wild-type TIMM50
grown in glucose or galactose. Data are shown as mean  SD, n = 5 or 4 biological replicates in the case of transduced cells; ***P < 0.001, Student’s unpaired two-
tailed t-test. Exact P-values are reported in Table EV1.
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could be responsible for the lower levels of protein detected in
patient fibroblasts compared to control, due to nonsense-mediated
decay. The strong reduction in TIMM50 amount also suggests partial
instability of the mutant protein with the p.G190A missense muta-
tion. We showed that lower levels of TIMM50S lead to instability of
the TIM23 complex and as a consequence a decrease in the other
components of the complex, TIMM23 and TIMM17A/B, and
DNAJC19 with drastic consequences for the TIM23 import pathway.
On the other hand, the missense change p.G190A (p.G87A in the
mitochondrial TIMM50S sequence) hits the second last amino acid
of the transmembrane domain. Glycine is a very flexible residue, and
it has been replaced by alanine, which normally creates a kink in the
structure. This change may alter the capacity of the presequence
binding domain (PBD) of TIMM50 to interact with the other
A
C
B
D
E F
Figure 7. Characterization of RNASEH1 and ISCU mutant fibroblasts.
A Western blot of whole cell extracts for TIMM50 and GAPDH in control and TIMM50, RNASEH1, and ISCU mutant fibroblasts grown in either glucose- or galactose-
containing medium. Other components of the protein import machinery are shown in Appendix Fig S8A and their quantification in Appendix Fig S8B.
B Mitochondrial membrane potential in control and TIMM50, RNASEH1, and ISCU mutant fibroblasts grown in glucose or galactose using JC-1 staining in untreated or
FCCP-treated conditions. Data are shown as mean  SD, n = 4 biological replicates; *P < 0.05, **P < 0.01, ***P < 0.001, Student’s unpaired two-tailed t-test. Exact
P-values are reported in Table EV1.
C Western blot for representatives of all five respiratory complexes in control and TIMM50, RNASEH1, and ISCU mutant fibroblasts grown in glucose or galactose. GAPDH
is from the same blot as panel (A). Quantification based on two biological replicates for RNASEH1 and ISCU mutant fibroblasts is shown in Appendix Fig S9. Significant
changes in protein levels in RNASEH1 and ISCU mutant fibroblasts compared to controls have been boxed in red.
D Oxygen consumption measurements in control and TIMM50, RNASEH1, and ISCU mutant fibroblasts grown in glucose or galactose. Values of basal and maximal
respiration along with ATP production-dependent, proton leak respiration, and spare capacity are shown. Data are shown as mean  SD, n = 4 biological replicates;
*P < 0.05, **P < 0.01, ***P < 0.001, Student’s unpaired two-tailed t-test. Exact P-values are reported in Table EV1.
E Steady-state levels of ROS-related proteins SOD2 and ACO2 and mitophagy-related proteins VDAC1, p62, and LC3 in control and TIMM50, RNASEH1, and ISCUmutant
fibroblasts growing in either glucose or galactose were assessed by Western blot using GAPDH as internal control. GAPDH is from the same blot as panel (A). Quantification
is shown in Appendix Fig S10. Significant changes in protein levels in RNASEH1 and ISCUmutant fibroblasts compared to controls have been boxed in red.
F Quantification of the number of late apoptotic cells in control and TIMM50, RNASEH1, and ISCU mutant fibroblasts grown in glucose or galactose. Data are shown as
mean  SD, n = 4 or more biological replicates; ***P < 0.001, Student’s unpaired two-tailed t-test. Exact P-values are reported in Table EV1.
Source data are available online for this figure.
10 of 15 EMBO Molecular Medicine e8698 | 2018 ª 2018 The Authors
EMBO Molecular Medicine TIMM50 and mitochondrial diseases Aurelio Reyes et al
Published online: September 6, 2018 
components of the TIM23 complex, and as a consequence, the chan-
nel may not close tightly at resting state, leading to the dissipation of
membrane potential that we observed in the patient fibroblasts,
which was rescued by transduction with TIMM50. Indeed, yeast
Tim50, and more precisely the PBD, has been shown to induce the
closure of the Tim23 channel and hence maintain mitochondrial
membrane potential (Meinecke et al, 2006). Moreover, Tim50 PBD
is responsible for the precursor handover from Tom22 to Tim23,
causing conformational changes that open the Tim23 channel and
allow import progression (Qian et al, 2011; Schulz et al, 2011,
2015). Thus, mutations affecting the flexibility of the PDB and/or its
ability to interact either with the presequence or other import subu-
nits are expected to directly affect import rate in the TIM23 pathway.
Indeed, we have shown that import of TFAM is severely impaired in
patient fibroblasts but restored in TIMM50 transduced cells, whereas
import of AAC1 is as efficient as in controls. TFAM is imported via
the TIM23 complex, while ACC1 requires active TIM22 complex and
the import of both proteins is dependent on membrane potential
(Reyes et al, 2011; Vukotic et al, 2017). Hence, residual membrane
potential observed in the patient may be enough to allow the import
of both proteins, at least in isolated mitochondria. Indeed, RNASEH1
and ISCU mutant fibroblasts display similar low membrane potential
to TIMM50 mutant fibroblasts but no effect on mitochondrial import
was observed. While normal levels of TIM22 complex result in effi-
cient ACC1 import, the decrease in TIM23 complex and its lower
presequence handover efficiency can be responsible for the impaired
TFAM import. In Trypanosoma brucei, Tim50 knock-down also
resulted in less efficient import of TIM23-imported MRP2 and COIV,
with no significant effect on ACC1 import, despite a 25% decrease in
mitochondrial membrane potential (Duncan et al, 2013). Likewise,
partial depletion of Tim50 in yeast resulted in mtHsp60 import
impairment without any effect on ACC (Yamamoto et al, 2002).
Although a pathogenic mutation in human TIMM50 failed to be asso-
ciated with import impairment (Shahrour et al, 2017), we noticed
that Shahrour et al (2017) used yeast as an in vivo model system to
validate the mutation, despite the fact that human TIMM50 cannot
rescue the phenotype of yeast DTim50 and the global conservation
between these two proteins is very poor.
Impairment of the mitochondrial import system is expected to
have dramatic consequences for the cell, and indeed, we have
observed significant reduction of some OxPhos subunits in glucose-
grown cells that can be rescued by transduction with TIMM50 and
is only partially present in ISCU but not in RNASEH1 mutant fibrob-
lasts, most likely due to alterations in iron-sulfur metabolism in the
former. However, not all complexes are equally affected, and signifi-
cant differences were only detected for complexes I, II, and IV. The
use of MitoBloCK-6, a small molecule that impairs mitochondrial
protein import, has also been reported to produce the same result in
HeLa cells (Quiros et al, 2017). Although this differential effect on
the level of OxPhos subunits is poorly understood, it could be
explained as a consequence of different factors, as follows. First, (i)
protein steady-state levels are a balance between new synthesis and
degradation, and therefore, the half-life of a protein can be altered
in a protein-specific way when synthesis, or import, as in this case,
is impaired. Second, (ii) submitochondrial localization requires the
use of either TIM23-PAM for matrix proteins or TIM23SORT for inner
membrane proteins, and in the latter pathway, interaction with
TIMM21 leads to their stabilization in subcomplexes, thus
preventing their degradation, as it has been shown in HEK293 cells
for NDUFB8, which interacts with TIMM21, compared to NDUFS6,
which does not (Mick et al, 2012). These results are in agreement
with those of Tim50 depletion in yeast, where import of matrix
proteins was strongly affected, whereas inner membrane-targeted
proteins were much less dependent on integrity of Tim50 (Schend-
zielorz et al, 2017). Third, (iii) protein import may be efficient even
in conditions of low TIM23 complex and/or absence of mitochon-
drial membrane potential, as already described for small single-
spanning inner membrane complex V (ATP5I/Su e) and for a
complex III (Qcr10) subunits in yeast (Turakhiya et al, 2016). In
yeast depleted of Tim50, import of some mitochondrial matrix
proteins is impaired in the presence of only minor changes in the
mitochondrial membrane potential, while other proteins are hardly
affected except when the membrane potential is severely decreased,
being this feature not dependent on the presequence but rather on
the mature portion of the protein (Schendzielorz et al, 2017).
Finally, (iv) some proteins may be able to be imported using alter-
native pathways to overcome import defects, as suggested by the
yeast phosphate carrier, which can be imported by either the TIM22
or the TIM23 pathways (Yamano et al, 2005). As already
mentioned, the import deficiency detected in our TIMM50 mutant
cells results in lower levels of some OxPhos proteins causing a
reduction of both basal and maximal mitochondrial respiration, as
well as ATP-dependent respiration, and transduction with TIMM50
substantially rescued this deficiency, albeit not reaching control
levels. HeLa cells treated with MitoBloCK-6 also displayed a
decrease in mitochondrial respiration (Quiros et al, 2017), and
Ttm50 depletion in Drosophila leads to reduced respiratory activity
(Sugiyama et al, 2007). By contrast, RNASEH1 and ISCU mutant
fibroblasts showed no or a small decrease in mitochondrial respira-
tion. OxPhos deficiency has also been associated with ROS produc-
tion and, accordingly, we detected a slight increase in ROS in
untreated cells that becomes more apparent after exposure to hydro-
gen peroxide. MitoBloCK-6-treated HeLa cells also display elevated
ROS production (Quiros et al, 2017). In agreement with these
results, we found increased levels of two proteins, SOD2 and ACO2,
involved in the conversion of superoxide anion into hydrogen
peroxide, which will be further eliminated by catalase and
glutathione system. VDAC1 also plays a role in ROS detoxification
by mediating the superoxide anion release from mitochondria to
cytosol, where it is a substrate of cytosolic SOD1 (Han et al, 2003).
This may explain why VDAC1 is increased in patient cells. Signifi-
cant upregulation of VDAC1 has also been reported in T. brucei
Tim50 knock-down, whereas Tim50 overexpression leads to its
downregulation (Duncan et al, 2013). Moreover, VDAC1 can also
be ubiquitinated by Parkin, triggering ROS-mediated mitophagy
(Geisler et al, 2010). The reduction of p62 and increase of the lipi-
dated form of LC3 are markers of increased autophagic flux, and
both features are present in the patient cells, pointing to a slight
increase in mitophagy. All these metabolic changes can be attrib-
uted to the lack of TIMM50 since patient fibroblasts complemented
with TIMM50 presented values comparable to controls in all cases
and they were not observed in RNASEH1 and ISCU mutant fibrob-
lasts, with the exception of lower p62 levels. As a consequence of
these metabolic alterations, TIMM50 mutant fibroblasts displayed a
clear cellular phenotype characterized by smaller cell size and
slower growth rate that was, at least, partially reverted by
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transduction with TIMM50. Several lines of evidence support these
observations: TIMM50 stable silencing in human breast cancer cell
lines suppresses cell proliferation (Gao et al, 2016); Ttm50-depleted
Drosophila has a diminutive body due to a reduction in both size
and number of cells caused by cell growth and proliferation defects
(Sugiyama et al, 2007); and Tim50 knock-down in T. brucei
produces a slow growth phenotype (Duncan et al, 2013). Haploin-
sufficiency of Tim23 in the heterozygous Tim23 knockout mouse
has also been correlated with a markedly reduced life span (Ahting
et al, 2009). However, this cellular phenotype is not unique to
TIMM50 mutations, as we can also observe it in ISCU mutant fibrob-
lasts, albeit not so pronounced.
It has long been known that cells growing in glucose utilize both
glycolysis and OxPhos for ATP production, with fibroblasts mainly
relying on a glycolytic metabolism, whereas cells growing in galac-
tose are almost entirely dependent on OxPhos (Reitzer et al, 1979).
The underlying reason is that glycolytic metabolism of glucose
yields two net ATP molecules, while no net ATP is produced from
galactose, forcing the cells to rely on OxPhos for energy. Indeed,
growth in galactose increased the levels of most respiratory chain
proteins in both control and all three mutant fibroblasts, and also in
cells transduced with either the empty vector or TIMM50, resulting
in higher respiration and ATP production, a phenomenon also
reported in human primary myotubes (Aguer et al, 2011) and
cancer cells (Rossignol et al, 2004). Despite this metabolic switch,
no significant increase in the levels of ROS and related proteins was
detected in galactose compared to glucose. By contrast, mitophagy
markers p62 and LC3-II were both upregulated in galactose-grown
cells without significant differences among cell lines. Thus, TIMM50
mutant fibroblasts grown in galactose seem to have a relatively
milder biochemical phenotype than those grown in glucose, which
sharply contrasts with their strong reduction in cell growth and
huge increase in apoptosis, an effect also seen in human primary
skin fibroblasts from other patients with a variety of OxPhos
deficiencies (Robinson et al, 1992). TIMM50 depletion has also
proven to induce apoptosis in human breast cancer cell lines (Gao
et al, 2016), whereas Tim50 loss of function in zebrafish resulted in
massive apoptosis in the central nervous system associated with
cytochrome c release (Guo et al, 2004). Moreover, mutant hunt-
ingtin specifically associates with the TIM23 complex and directly
inhibits protein import, triggering neuronal cell death in mouse
(Yano et al, 2014). A significant cell growth defect was also
observed in ISCU mutant fibroblasts but in this case, it was not asso-
ciated with increased apoptosis. These results highlight the impor-
tance of healthy mitochondrial function in tissues with high energy
demand and show how the analysis of patient cells growing in
galactose vs. glucose can provide an insight into the effect that these
mutations may have in OxPhos-dependent tissues and organs.
Materials and Methods
Human subjects
Informed consent was obtained from all subjects included in the
study, and the experiments conformed to the principles set out in
the WMA Declaration of Helsinki and the Department of Health and
Human Services Belmont Report.
Whole exome sequencing analysis
Whole exome sequencing analysis was applied to 50 ng of
genomic DNA from TIMM50 Pt. Nextera Rapid Exome Capture
Kit (Illumina) was used for exome enrichment according to
manufacturer’s instructions. Exome sequencing was performed by
Illumina MiSeq next-generation sequencing platform with 600-bp
pair-end sequencing strategy. Sequences from the FASTAQ files
were aligned to the human genome (hg19) by using the BWA
aligner. Variants were called by using the GATK HaplotypeCaller
and then filtered by using the Variant Quality Score Re-calibra-
tion according to the best practices of GATK-2.7 (https://www.
broadinstitute.org/gatk/). Variants were annotated by using
ANNOVAR. Coverage of the targeted regions was estimated using
the GATK DepthOfCoverage. For paired-end reads to be included,
they needed to have a mapping quality >20 and a base quality
>10.
Cell culture and transduction
Fibroblast cell lines were maintained in high-glucose medium
(Gibco) supplemented with 10% FBS (Gibco), 1% penicillin-strep-
tomycin, and 100 lg/ml uridine at 37°C in a humidified atmo-
sphere of 5% CO2. Primary skin fibroblasts were immortalized by
lentiviral transduction of pLOX-Ttag-iresTK (Addgene #12246,
Tronolab). For the generation of lentiviral particles, human 293T
cells (2.5 × 106) were plated 24 h before cotransfection with 10 lg
of transfer vector (pLOX-Ttag-iresTK), 7.5 lg of second-generation
packaging plasmid (pCMVdR8.74), and 3 lg of envelope plasmid
(pMD2.VSVG; Naldini et al, 1996). FuGENE 6 Transfection Reagent
(Roche) was used as transfectant reagent. Infectious particles were
collected 24 and 48 h after transfection. Transduced fibroblasts
were grown for at least six passages in order to make sure immor-
talized cells were selected. Changes in cell shape and doubling
time were observed as part of the normal process of immortaliza-
tion. Complementation experiments on immortalized fibroblasts
used wild-type TIMM50S cloned into pWPXL-ires-HygroR lentiviral
expression vector, a modified version of pWPXLd (Addgene
#12258, Tronolab) or the empty vector itself. Lentiviral particles
were generated as described above, and transduced fibroblasts
were selected for hygromycin resistance. When required, high-
glucose medium was replaced by glucose-free medium (Gibco) and
supplemented with 50 mM galactose (Sigma) for 5 days. Unless
specified otherwise, all experiments were carried out on immortal-
ized skin fibroblasts.
Immunoblot analysis
Protein gel electrophoresis and blotting analyses were performed in
fibroblasts (either naı¨ve, immortalized cells and complemented)
from patients and controls A and B. Samples from cell lysates
containing 10 lg protein were separated by denaturing NuPAGE 4–
12% Bis-Tris gels and transferred to nitrocellulose membrane.
Immunodetection was carried out using antibodies against target
proteins and GAPDH as loading control. In the case of cellular frac-
tions, protein load was made equivalent to whole cell extract lane.
A list of antibodies used in the present study is shown in
Appendix Table S1.
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ROS measurement
Reactive oxygen species (ROS) was measured by monitoring intra-
cellular oxidation of the cell-permeant probe 20-70 dichlorofluores-
cein diacetate (H2DCFDA) in a spectrofluorimeter. Control and
patient fibroblasts (35 × 103 cells) grown in 96-well plates in
glucose- or galactose-containing media were left untreated or treated
with 250 lM H2O2 for 30 min before being incubated with 9 lM
DCFDA in HBSS for 10–40 min, and fluorescence was measured at
Ex 488 nm, Em 525 nm. Next, cells were lysed in 50 mM Tris–HCl
7.4/150 mM NaCl/1 mM EDTA/0.1% Triton and proteins were
quantified. Fluorescence values were normalized to protein load.
Annexin V assay
Quantification of apoptotic cells was carried out by measuring
Annexin V and propidium iodide in a NucleoCounter NC-3000
Advanced Image Cytometer and following the manufacturer’s
recommendations.
Oxygen consumption
Respiration in skin fibroblasts, IO2 [pmolss1106 cells], was calcu-
lated as the negative time derivate of oxygen concentration as
measured by the OROBOROS Oxygraph-2k on one million cell/ml in
a 2-ml chamber at 37°C. Basal respiration was measured without
substrates and the proton leak state after the addition of oligomycin
(50 nM). Oxygen consumption coupled to ATP production was
calculated as the difference between basal respiration and proton
leak. Maximal respiration was measured by stepwise 1.25 lM titra-
tion of CCCP and inhibition by 2 lM rotenone and 2.5 lM anti-
mycin A for the final measurement of residual oxygen consumption.
Spare capacity was calculated as the difference between maximal
respiration and basal respiration.
Membrane potential
Mitochondrial membrane potential was measured in untreated cells
and after treatment with 1 lM FCCP for 5 min at 37°C as ratio of red to
green JC-1 signal using a NucleoCounter NC-3000 Advanced Image
Cytometer. In addition, confocal analysis based on the use of TMRM
was also performed. Fibroblasts were washed with PBS twice and live-
stained with 20 nM TMRM for 20 min. After washing three times with
PBS, cells were imaged with a ZEISS ApoTome fluorescence micro-
scope using a 40× objective within five minutes after staining.
In organello import of radiolabeled proteins
[35S]-methionine-labeled proteins were generated with the TNT
Quick Coupled Transcription/Translation System (Promega) accord-
ing to the manufacturer’s instructions. Labeled proteins were incu-
bated with isolated mitochondria prepared by differential
centrifugation from control and patient fibroblasts grown in glucose
(Reyes et al, 2011) and import were carried out at 37°C for 1–
30 min. A negative control containing 1 lM FCCP was included for
the longest time point. Mitochondria from TFAM import reactions
were washed three times before being subjected to SDS–PAGE,
while in AAC1 import experiments, mitochondria were trypsin
treated for 15 min at 37°C before the washes and SDS–PAGE. Gels
were dried, exposed to storage phosphor screens (GE Healthcare),
visualized on the Typhoon 9410 Variable Mode Imager (Amersham
Biosciences), and quantified using ImageJ.
qPCR
RNeasy mini kit (QIAGEN) and GoTaq 2-Step RT-qPCR System
(Promega) were used for RNA purification from fibroblasts and
cDNA retrotranscription, respectively, according to the manufactur-
ers’ protocols. The expression levels of TIMM50 and the housekeep-
ing genes GAPDH and ACTB were analyzed by GoTaq qPCR Master
Mix (Promega), using the SYBR green chemistry. Primer sequences
were as follows: TIMM50 I (GGGACTGTGCACGAGGTT and
CCTTGCGCCTTAGTGCTC), TIMM50 II (CTTTCAAACAGCGGCAAA
and GGAGCCAAGGAAGAGGTTCT), GAPDH (CTCTGCTCCTCCT
GTTCGAC and ACGACCAAATCCGTTGA), and ACTB (CCAACCGC
GAGAAGATGA and CCAGAGGCGTACAGGGAT).
Statistical analysis
Fibroblasts from a single patient with mutations in TIMM50 and two
non-related healthy individuals along with two fibroblasts cell lines
from patients with mutations in other genes affecting mitochondrial
function were also analyzed as controls. All numerical data are
expressed as mean  standard deviation of the mean (SD). Student’s
unpaired two-tailed t-tests under the assumption of normal distribu-
tion and unequal variance were used for statistical analysis combining
the data from both controls against the TIMM50 patient unless speci-
fied otherwise. In complementation experiments, non-complemented,
and complemented with either empty vector or TIMM50S, patient-
derived cell lines were compared to the corresponding control B cell
line that was randomly chosen for these experiments.
Data availability
The datasets produced in this study are available in the following
databases:
Whole exome sequencing: ClinVar SCV000788332 (https://www.ncbi.
nlm.nih.gov/clinvar/variation/559480/) and SCV000788354 (https://
www.ncbi.nlm.nih.gov/clinvar/variation/559479/).
Expanded View for this article is available online.
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